Public articles linked to the same research event.
Facial Plastic Surgery This is a forward-looking article examining the emerging role of personalized medicine in facial plastic surgery, proposing that biologically, anatomically, and psychologically tailored approaches may refine both aesthetic and reconstructive care, and suggesting that genomics, pharmacogenomics, artificial intelligence, tissue engineering, and three-dimensional modelling may improve prediction of healing, treatment response, complication risk, and reconstructive requirements, while emphasizing that ethical challenges relating to privacy, bias, and equitable access must remain central.
This is a forward-looking article examining the emerging role of personalized medicine in facial plastic surgery, proposing that biologically, anatomically, and psychologically tailored approaches may refine both aesthetic and reconstructive care, and suggesting that genomics, pharmacogenomics, artificial intelligence, tissue engineering, and three-dimensional modelling may improve prediction of healing, treatment response, complication risk, and reconstructive requirements, while emphasizing that ethical challenges relating to privacy, bias, and equitable access must remain central.
This is a forward-looking article examining the emerging role of personalized medicine in facial plastic surgery, proposing that biologically, anatomically, and psychologically tailored approaches may refine both aesthetic and reconstructive care, and suggesting that genomics, pharmacogenomics, artificial intelligence, tissue engineering, and three-dimensional modelling may improve prediction of healing, treatment response, complication risk, and reconstructive requirements, while emphasizing that ethical challenges relating to privacy, bias, and equitable access must remain central.
This is a forward-looking article examining the emerging role of personalized medicine in facial plastic surgery, proposing that biologically, anatomically, and psychologically tailored approaches may refine both aesthetic and reconstructive care, and suggesting that genomics, pharmacogenomics, artificial intelligence, tissue engineering, and three-dimensional modelling may improve prediction of healing, treatment response, complication risk, and reconstructive requirements, while emphasizing that ethical challenges relating to privacy, bias, and equitable access must remain central.